← back to search

Jens Peter Klußmann

Düsseldorf University Hospital · DE
Area of research
Otorhinolaryngology · Surgery
Research interest
Research interests include Head and Neck Cancer Studies, Salivary Gland Tumors Diagnosis and Treatment, Cervical Cancer and HPV Research, and Esophageal Cancer Research and Treatment.
h-index
57
citations
11,293
works
479
NIH funding
primary concept
Medicine
email

Recent publications

Evaluation of an HPV16-L1 antibody rapid test for oropharyngeal cancer diagnosis: diagnostic accuracy and challenges in real-world settings
eBioMedicine 2026cited by 1position: contributordoi
Vocal fold augmentation with autologous fat following transoral laryngeal surgery.
2026cited by 0position: contributordoi
An agentic framework for autonomous scientific discovery in cancer pathology.
2026cited by 0position: contributordoi
Genomic Enrichment and Functional Impact of TP53 and CYLD Alterations in Recurrent and Metastatic HPV-Associated Head and Neck Cancer.
2026cited by 0position: contributordoi
Radiological Features of Human Papillomavirus (HPV)-Positive and HPV-Negative Oropharyngeal Squamous Cell Carcinoma (OPSCC)—Considerations for Multimodal Analysis
Cancers 2026cited by 0position: contributordoi
Evaluation of an HPV16-L1 antibody rapid test for oropharyngeal cancer diagnosis: diagnostic accuracy and challenges in real-world settings
EBioMedicine 2025cited by 1position: middledoi
Local T-Cell Dysregulation and Immune Checkpoint Expression in Human Papillomavirus-Mediated Recurrent Respiratory Papillomatosis.
2025cited by 0position: contributordoi
Quantification of human papillomavirus cell-free DNA from low-volume blood plasma samples by digital PCR
Microbiology Spectrum 2024cited by 6position: middledoi
Combination of nivolumab with standard induction chemotherapy in children and adults with EBV-positive nasopharyngeal carcinoma
HNO 2024cited by 4position: middledoi
Analysis of Expression and Regulation of AKR1C2 in HPV-Positive and -Negative Oropharyngeal Squamous Cell Carcinoma.
2024cited by 1position: contributordoi
Cochlear measurement in computed tomography and magnetic resonance imaging data sets by the Otoplan measurement tool: a retrospective comparative study.
2024cited by 1position: contributordoi
Prognostic implications of p16 and HPV discordance in oropharyngeal cancer (HNCIG-EPIC-OPC): a multicentre, multinational, individual patient data analysis
The Lancet Oncology 2023cited by 275position: middledoi
Predicting HPV association using deep learning and regular H&E stains allows granular stratification of oropharyngeal cancer patients
npj Digital Medicine 2023cited by 21position: lastdoi
Predictors for Survival of Patients with Squamous Cell Carcinoma of Unknown Primary in the Head and Neck Region
Cancers 2023cited by 6position: middledoi
Predictors for Survival of Patients with Squamous Cell Carcinoma of Unknown Primary in the Head and Neck Region.
2023cited by 4position: contributordoi
Peroxisomes Are Highly Abundant and Heterogeneous in Human Parotid Glands.
2023cited by 2position: contributordoi
Table S5 from Deep Learning Predicts HPV Association in Oropharyngeal Squamous Cell Carcinomas and Identifies Patients with a Favorable Prognosis Using Regular H&E Stains
2023cited by 0position: contributordoi
Table S5 from Deep Learning Predicts HPV Association in Oropharyngeal Squamous Cell Carcinomas and Identifies Patients with a Favorable Prognosis Using Regular H&E Stains
2023cited by 0position: contributordoi
Data from Deep Learning Predicts HPV Association in Oropharyngeal Squamous Cell Carcinomas and Identifies Patients with a Favorable Prognosis Using Regular H&E Stains
2023cited by 0position: contributordoi
Table S2 from Deep Learning Predicts HPV Association in Oropharyngeal Squamous Cell Carcinomas and Identifies Patients with a Favorable Prognosis Using Regular H&E Stains
2023cited by 0position: contributordoi
Table S4 from Deep Learning Predicts HPV Association in Oropharyngeal Squamous Cell Carcinomas and Identifies Patients with a Favorable Prognosis Using Regular H&E Stains
2023cited by 0position: contributordoi
Table S1 from Deep Learning Predicts HPV Association in Oropharyngeal Squamous Cell Carcinomas and Identifies Patients with a Favorable Prognosis Using Regular H&E Stains
2023cited by 0position: contributordoi
Data from Deep Learning Predicts HPV Association in Oropharyngeal Squamous Cell Carcinomas and Identifies Patients with a Favorable Prognosis Using Regular H&E Stains
2023cited by 0position: contributordoi
Table S3 from Deep Learning Predicts HPV Association in Oropharyngeal Squamous Cell Carcinomas and Identifies Patients with a Favorable Prognosis Using Regular H&E Stains
2023cited by 0position: contributordoi
Supplementary Figures from Deep Learning Predicts HPV Association in Oropharyngeal Squamous Cell Carcinomas and Identifies Patients with a Favorable Prognosis Using Regular H&E Stains
2023cited by 0position: contributordoi
Supplementary Figures from Deep Learning Predicts HPV Association in Oropharyngeal Squamous Cell Carcinomas and Identifies Patients with a Favorable Prognosis Using Regular H&E Stains
2023cited by 0position: contributordoi
Table S2 from Deep Learning Predicts HPV Association in Oropharyngeal Squamous Cell Carcinomas and Identifies Patients with a Favorable Prognosis Using Regular H&E Stains
2023cited by 0position: contributordoi
Table S1 from Deep Learning Predicts HPV Association in Oropharyngeal Squamous Cell Carcinomas and Identifies Patients with a Favorable Prognosis Using Regular H&E Stains
2023cited by 0position: contributordoi
Table S4 from Deep Learning Predicts HPV Association in Oropharyngeal Squamous Cell Carcinomas and Identifies Patients with a Favorable Prognosis Using Regular H&E Stains
2023cited by 0position: contributordoi
Table S3 from Deep Learning Predicts HPV Association in Oropharyngeal Squamous Cell Carcinomas and Identifies Patients with a Favorable Prognosis Using Regular H&E Stains
2023cited by 0position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 35 papers (2020–2026)Magnus von Knebel Doeberitz · Hospital Sírio-Libanês27 papers (2014–2023) · 24 papers (2020–2025) · 23 papers (2020–2023)Steffen Wagner · Justus-Liebig-Universität Gießen22 papers (2014–2023)Christine Langer · Justus-Liebig-Universität Gießen17 papers (2021–2023) · 17 papers (2020–2023)Hans Christian Reinhardt · Düsseldorf University Hospital17 papers (2020–2023) · 15 papers (2021–2023)Claus Wittekindt · Witten/Herdecke University14 papers (2014–2023)Elena‐Sophie Prigge · German Cancer Research Center10 papers (2014–2023)Ernst‐Jan M. Speel · Maastricht University Medical Centre8 papers (2015–2023)Nora Wuerdemann · Universitätsklinik für Hals-, Nasen- und Ohrenheilkunde8 papers (2017–2024) · 7 papers (2015–2023) · 6 papers (2017–2023)Miriam Reuschenbach · MSD (Germany)6 papers (2014–2019)Andreas Dietz · Accadis Hochschule Bad Homburg5 papers (2014–2025)Shachi Jenny Sharma · Centrum für Integrierte Onkologie5 papers (2017–2023)Alexander Quaas · Heinrich Heine University Düsseldorf5 papers (2019–2025)Tim Waterboer · German Cancer Research Center4 papers (2020–2025)